Skip to main content
. Author manuscript; available in PMC: 2010 May 18.
Published in final edited form as: Hum Reprod. 2009 Feb 26;24(6):1436–1445. doi: 10.1093/humrep/dep039

Table I.

Number of genes significantly modulated in 6 microarray analyses comparing the pre-receptive or receptive stages between natural and stimulated cycles.

Study Number of samples Natural cycle (number of samples) Stimulated cycle (number of samples) Paired analysis Fold change Number of genes
Up Down
Mirkin et al. (2004) 13 LH+8 (n=5) hCG+9 Atg (n=5) Partially ≥ 1.19 6 6
LH +8 (n=5) hCG+9 Ag (n=3) ≥ 1.2 5 1

Horcajadas et al. (2005) 19 LH +7 (n=14) hCG +7 (n=5) No ≥ 3 281 277

Simon et al. (2005) 28 LH +7 (n=14) hCG +7 Atg standard dose (n=4) No ≥ 2 22 69
LH +7 (n=14) hCG +7 Atg high dose (n=5) 88 24
LH +7 (n=14) hCG +7 Ag (n=5) 22 100

Horcajadas et al. (2008) 49 LH+1 (n=5) hCG+1 (n=5) No - 0 0
LH+2 (n=5) hCG+2 (n=5) 0 0
LH+3 (n=5) hCG+3 (n=5) 0 0
LH+5 (n=5) hCG+5 (n=4) 0 0
LH+7 (n=5) hCG+7 (n=5) 69 73
LH+9 (n=5) hCG+9 (n=5) 0 0

Liu et al. (2008) 13 LH+7 (n=5) hCG+7 high serum E2 levels (n=4) No ≥ 2 244 159
LH+7 (n=5) hCG+7 low serum E2 levels (n=4) 5 2

Current study 84 LH+2 (n=21) hCG+2 (n=21) Yes ≥ 2 321 4
LH+7 (n=21) hCG+5 (n=21) 657 0

This table compares our gene lists significantly modulated between LH+2 and hCG+2, and between LH+7 and hCG+5 with five other studies using the same approach. Atg, antagonist; Ag, agonist.